- Home
- ORMP vs GF Comparison
ORMP vs GF Comparison
Compare ORMP & GF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ORMP | GF |
|---|---|---|
| Founded | 2002 | 1990 |
| Country | United States | Germany |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 165.3M | 191.2M |
| IPO Year | 2010 | N/A |
Fundamental Metrics
Financial Performance| Metric | ORMP | GF |
|---|---|---|
| Price | $3.71 | $11.87 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 218.5K | 61.6K |
| Earning Date | 05-14-2026 | 01-01-0001 |
| Dividend Yield | ★ 6.51% | 0.82% |
| EPS Growth | ★ 412.50 | N/A |
| EPS | ★ 0.91 | N/A |
| Revenue | ★ $2,000,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $4.19 | ★ N/A |
| Revenue Growth | ★ 49.25 | N/A |
| 52 Week Low | $1.98 | $9.98 |
| 52 Week High | $5.01 | $12.82 |
Technical Indicators
Market Signals| Indicator | ORMP | GF |
|---|---|---|
| Relative Strength Index (RSI) | 40.99 | 49.97 |
| Support Level | $3.21 | $11.74 |
| Resistance Level | $3.80 | $12.39 |
| Average True Range (ATR) | 0.27 | 0.31 |
| MACD | -0.08 | -0.02 |
| Stochastic Oscillator | 9.91 | 49.49 |
Price Performance
Historical ComparisonAbout ORMP Oramed Pharmaceuticals Inc.
Oramed Pharmaceuticals Inc is a pharmaceutical company that is engaged in the research and development of pharmaceutical solutions with a technology platform that allows for the oral delivery of therapeutic proteins. The company has developed an oral dosage form intended to withstand the harsh environment of the gastrointestinal tract and effectively deliver active insulin or other proteins. Its product pipeline includes ORMD-0801 for Diabetes, ORMD-0801 for NASH, and ORMD 0901.
About GF New Germany Fund Inc. (The)
NEW GERMANY FUND INC is a non-diversified, closed-end management investment company. As the investment objective, the fund seeks long-term capital appreciation through investment in middle-market German equities. The fund's portfolio of investments includes investments in different sectors such as the industrials, information technology, materials, consumer discretionary, Communication Services, Financials, Consumer Staples, Real Estate, Utilities, Healthcare, Energy, and others. Its portfolio is geographically diversified across the Netherlands, Germany, and Luxembourg.